Skip to main content
OpenTrials

Clinical trial condition

Mononegavirales Infections

Explore clinical trials studying Mononegavirales Infections. Study availability and eligibility vary by location and protocol.

536 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Mononegavirales Infections trial results

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

NCT01621802

Conditions
Infections, Measles, Measles-Mumps-Rubella, +12 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Benton, Arkansas, United States
View all 67 locations
View Trial Details
Completed

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

NCT01702428

Conditions
Infections, Measles, Mononegavirales Infections, +14 more
Locations
  • GSK Investigational Site Dothan, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
  • GSK Investigational Site Anaheim, California, United States
View all 90 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.

NCT02878330

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Anaheim, California, United States
  • Research Site Anaheim, California, United States
  • Research Site Downey, California, United States
View all 161 locations
View Trial Details

Related conditions